BTBenjamin Twum

Benjamin Twum

*This is an algorithmically generated author record based on publicly available information.

Benjamin Twum has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Abdul-Waliu Iddrisu

    Affiliation Department of Biomedical Laboratory Sciences, School of Allied Health Sciences, University for Development Studies, Tamale, Ghana

    1 shared publication
  • Abidatu Mohammed

    Affiliation Department of Biomedical Laboratory Sciences, School of Allied Health Sciences, University for Development Studies, Tamale, Ghana

    1 shared publication
  • Caleb Paul Eshun

    Affiliation Department of Biomedical Laboratory Sciences, School of Allied Health Sciences, University for Development Studies, Tamale, Ghana

    1 shared publication
  • Candy Adwoa Ewusiwaa Wilson

    Affiliation Department of Biomedical Laboratory Sciences, School of Allied Health Sciences, University for Development Studies, Tamale, Ghana

    1 shared publication
  • Charles Angnataa Derigubah

    Affiliation Department of Medical Laboratory Technology, School of Applied Science and Arts, Bolgatanga Technical University, Bolgatanga, Ghana

    1 shared publication
  • Charles Nkansah

    Department of Haematology, School of Allied Health Sciences, University for Development Studies, Tamale, Ghana

    1 shared publication

Latest Publications

  • Open Access

    Effects of COVID-19 disease on PAI-1 antigen and haematological parameters during disease management: A prospective cross-sectional study in a regional Hospital in Ghana

    by Charles Nkansah, Michael Owusu, Samuel Kwasi Appiah, Kofi Mensah, Simon Bannison Bani, Felix Osei-Boakye, Lawrence Duah Agyemang, Ezekiel Bonwin Ackah, Gabriel Abbam, Samira Daud, et al.

    Background: Individuals with COVID-19 experience thrombotic events probably due to the associated hypofibrinolysis resulting from the upregulation of plasminogen activator inhibitor-1 (PAI-1) antigen. This study evaluated plasma PAI-1 antigen levels and haematological parameters before treatment and after recovery from severe COVID-19 in Ghana. Materials and methods: This cross-sectional study was conducted at Sunyani Regional Hospital, and recruited 51 patients who had RT-PCR-confirmed SARS-CoV-2. Participants’ sociodemographic data and clinical characteristics were taken from the hospital records. Venous blood was taken before COVID-19 treatment commenced for FBC, PAI-1 and ferritin assays. FBC was assessed using an automated haematology analyzer, whilst plasma PAI-1 Ag and serum ferritin levels were assessed with sandwich ELISA. All the tests were repeated immediately after participants recovered from COVID-19. Results: Of the 51 participants recruited into the study, 78.4% (40) had non-severe COVID-19 whiles 21.6% (11) experienced a severe form of the disease. Severe COVID-19 participants had significantly lower haemoglobin (g/dL): 8.1 (7.3–8.4) vs 11.8 (11.0–12.5), p12/L: 2.9 (2.6–3.1) vs 3.4 (3.1–4.3), p = 0.001; HCT%: 24.8 ± 2.6 vs 35.3 ± 6.7, p9/L: 86.4 (62.2–91.8) vs 165.5 (115.1–210.3), p9/L: 11.6 (9.9–14.2) vs 5.4 (3.7–6.6), pppp12/L: 3.3 (2.9–4.0) vs 4.3 (3.4–4.6), p = 0.001; absolute granulocyte count x 109/L: 2.3 ± 1.0 vs 4.6 ± 1.8, p9/L: 135.0 (107.0–193.0) vs 229.0 (166.0–270.0), ppp<0.001 levels were reduced after a successful recovery from COVID-19 compared to the values at admission. Conclusion: Plasma PAI-1 Ag level was higher among severe COVID-19 participants. The COVID-19-associated inflammation could affect red blood cell parameters and platelets. Successful recovery from COVID-19, with reduced inflammatory response as observed in the decline of serum ferritin levels restores the haematological parameters. Plasma levels of PAI-1 should be assessed during the management of severe COVID-19 in Ghana. This will enhance the early detection of probable thrombotic events and prompts Physicians to provide interventions to prevent thrombotic complications associated with COVID-19.